Atea Pharmaceuticals Inc • AVIR

Capital at risk.

About Atea Pharmaceuticals Inc
Ticker
info
AVIR
Trading on
info
NASDAQ
ISIN
info
US04683R1068
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Jean-Pierre Sommadossi Ph.D.
Headquarters
info
225 Franklin Street, Boston, MA, United States, 02110
Employees
info
56
Website
info
https://ateapharma.com
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product candidate is AT-527, an oral antiviral candidate that is in Phase 3 SUNRISE-3 clinical trial for the treatment of patients with COVID-19. The company also develops bemnifosbuvir in combination with ruzasvir, which is in Phase 2 clinical trial, for the treatment of hepatitis C virus (HCV); and a protease inhibitor for the treatment of COVID-19. It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of Ruzasvir, an NS5A inhibitor, for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$274M
P/E ratio
info
-
EPS
info
-$2.00
Dividend Yield
info
0.00%
Beta
info
0.18
Forward P/E ratio
info
0
EBIDTA
info
$-132M
Ex dividend date
info
-
Price & volume
Market cap
info
$274M
Average daily volume
info
0.3M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
1.9
Price to book
info
0.62
Earnings
EPS
info
-$2.00
EPS estimate (current quarter)
info
-$0.29
EPS estimate (next quarter)
info
-$0.37
EBITDA
info
$-132M
Revenues (TTM)
info
$192M
Revenues per share (TTM)
info
$2.31
Technicals
Beta
info
0.18
52-week High
info
$4.15
52-week Low
info
$2.75
50-day moving average
info
$3.10
200-day moving average
info
$3.39
Short ratio
info
8.71
Short %
info
4.77%
Management effectiveness
ROE (TTM)
info
33.88%
ROA (TTM)
info
15.60%
Profit margin
info
0.00%
Gross profit margin
info
$-83.4M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
264.10%
Quarterly revenue growth (YoY)
info
295.20%
Share stats
Outstanding Shares
info
85.5M
Float
info
66.6M
Insiders %
info
11.66%
Institutions %
info
71.92%
Analyst Insights & forecasts
info

34% Buy

33% Hold

33% Sell

Based on information from 3 analysts.

Average price target

info
$7.07
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.75
-$0.61
22.95%
Q1 • 24Beat
-$0.48
-$0.76
36.84%
Q2 • 24Beat
-$0.37
-$0.49
24.49%
Q3 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-31.2M
∞%
Q3 • 24
$0M
$-33.5M
∞%
Q4 • 24
NaN%
7.68%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$491M
$32.4M
6.61%
Q3 • 24
$465M
$25.8M
5.55%
Q4 • 24
5.35%
20.46%
15.96%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-23M
$-122M
$0.1M
$-23M
Q3 • 24
$-30.4M
$-3.4M
$0M
$-30.4M
Q4 • 24
31.96%
97.24%
100.00%
31.96%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Atea Pharmaceuticals Inc share?
Collapse

Atea Pharmaceuticals Inc shares are currently traded for undefined per share.

How many shares does Atea Pharmaceuticals Inc have?
Collapse

Atea Pharmaceuticals Inc currently has 85.5M shares.

Does Atea Pharmaceuticals Inc pay dividends?
Collapse

No, Atea Pharmaceuticals Inc doesn't pay dividends.

What is Atea Pharmaceuticals Inc 52 week high?
Collapse

Atea Pharmaceuticals Inc 52 week high is $4.15.

What is Atea Pharmaceuticals Inc 52 week low?
Collapse

Atea Pharmaceuticals Inc 52 week low is $2.75.

What is the 200-day moving average of Atea Pharmaceuticals Inc?
Collapse

Atea Pharmaceuticals Inc 200-day moving average is $3.39.

Who is Atea Pharmaceuticals Inc CEO?
Collapse

The CEO of Atea Pharmaceuticals Inc is Dr. Jean-Pierre Sommadossi Ph.D..

How many employees Atea Pharmaceuticals Inc has?
Collapse

Atea Pharmaceuticals Inc has 56 employees.

What is the market cap of Atea Pharmaceuticals Inc?
Collapse

The market cap of Atea Pharmaceuticals Inc is $274M.

What is the P/E of Atea Pharmaceuticals Inc?
Collapse

The current P/E of Atea Pharmaceuticals Inc is null.

What is the EPS of Atea Pharmaceuticals Inc?
Collapse

The EPS of Atea Pharmaceuticals Inc is -$2.00.

What is the PEG Ratio of Atea Pharmaceuticals Inc?
Collapse

The PEG Ratio of Atea Pharmaceuticals Inc is null.

What do analysts say about Atea Pharmaceuticals Inc?
Collapse

According to the analysts Atea Pharmaceuticals Inc is considered a buy.